Discovery of nirmatrelvir resistance mutations in SARS-CoV-2 3CLpro: A computational-experimental approach

B Havranek, R Demissie, H Lee, S Lan… - Journal of chemical …, 2023 - ACS Publications
The COVID-19 pandemic has emphasized the urgency for effective antiviral therapies
against SARS-CoV-2. Targeting the main protease (3CLpro) of the virus has emerged as a …
被引用次数：7 相关文章

Discovery of Nirmatrelvir Resistance Mutations in SARS-CoV-2 3CLpro: A Computational-Experimental Approach.

B Havranek, R Demissie, H Lee, S Lan… - Journal of Chemical …, 2023 - europepmc.org
The COVID-19 pandemic has emphasized the urgency for effective antiviral therapies
against SARS-CoV-2. Targeting the main protease (3CLpro) of the virus has emerged as a …
[HTML] nih.gov

[HTML][HTML] Discovery of nirmatrelvir resistance mutations in SARS-CoV-2 3CLpro: A computational-experimental approach

B Havranek, R Demissie, H Lee, S Lan… - Journal of chemical …, 2023 - ncbi.nlm.nih.gov
The COVID-19 pandemic has emphasized the urgency for effective antiviral therapies
against SARS-CoV-2. Targeting the main protease (3CLpro) of the virus has emerged as a …

Discovery of Nirmatrelvir Resistance Mutations in SARS-CoV-2 3CLpro: A Computational-Experimental Approach

B Havranek, R Demissie, H Lee… - Journal of …, 2023 - pubmed.ncbi.nlm.nih.gov
The COVID-19 pandemic has emphasized the urgency for effective antiviral therapies
against SARS-CoV-2. Targeting the main protease (3CLpro) of the virus has emerged as a …